Impact BioMedical Inc. Announces Pricing of Initial Public Offering

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (NYSE American: IBO), a company that discovers and develops novel products and services in human health and well-being, today announced the pricing of its initial public offering of 1,500,000 shares of its common stock at a public offering price of $3.00 per share. The shares are expected to begin trading on The NYSE American Market on
September 16, 2024, under the ticker symbol “IBO.”

The closing of the offering is expected on September 17, 2024subject to satisfaction of customary closing conditions. In addition, Impact has granted the underwriters a 45-day option to purchase up to an additional 225,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. All shares of common stock are being offered by Impact Biomedical. Revere Securities, LLC is serving as book-running manager for the offering.